health Personalized mRNA Vaccines Show Durable T Cell Immunity Against TNBC
New research demonstrates individualized mRNA neoantigen vaccines successfully induce robust and lasting T cell responses in patients with triple-negative breast cancer (TNBC), offering a promising therapeutic avenue.
